Skip to main content
Top

05-06-2025 | Reactive Arthritis | Review Article

Reactive arthritis: a comprehensive journey through diagnostic findings

Authors: Chiara Giraudo, Davide Astorri, Monique Reijnierse

Published in: Skeletal Radiology

Login to get access

Abstract

Reactive arthritis, initially described at the beginning of the twentieth century, is characterized by a sterile articular inflammation occurring several days to weeks after a bacterial gastrointestinal or urogenital infection. The most common agents include Chlamydia trachomatis, Ureaplasma urealyticum, and Neisseria gonorrhea for the venereal type and Salmonella enteriditis, Shigella flexneri, Yersinia enterocolitica for the post-enteric type. The prevalence of reactive arthritis varies geographically but overall, worldwide, it is estimated as 1/1000 persons. It is more common in young adults (18 to 40 years old) and in terms of gender, there is not a significant difference between men and women for post-enteric infections while the risk of the endemic type is higher in men with a ratio of 9:1. Guidelines and diagnostic algorithms taking into account the identification of the etiological agent and the timing of infection have been proposed in the literature. Typically, it is an asymmetric mono- or oligo-arthritis with a predilection for the lower extremities falling under the spondyloarthritis umbrella having shared clinical features. At imaging, enthesitis is considered a hallmark of the disease although other typical signs of inflammatory joint disease such as synovitis, periostitis, and erosions can be detected taking advantage of the various radiological and hybrid techniques according to the affected areas.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Reactive arthritis: a comprehensive journey through diagnostic findings
Authors
Chiara Giraudo
Davide Astorri
Monique Reijnierse
Publication date
05-06-2025
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-025-04965-8

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest